Table 2.

Initial clinical presentation in 116 patients with sellar masses other than pituitary adenomas

Etiologic groups	% of pts with symptoms	MAL (n=19)	CYS (n=62)	BEN (n=25)	INF (n=10)
Preoperative sign/symptom
NEUROPSYCHIATRIC COMPLAINTS
Headache	34	3 (16)	29 (47)**	6 (24)	2 (20)
Dizziness	8	0	8 (13)	1 (4)	0
Hearing loss	4	1 (5)	2 (3)	2 (8)	0
Cognitive complaints	3	1 (5)	2 (3)	0	1 (10)
OPHTHALMOLOGIC DYSFUNCTIONS
Blurred vision/visual loss	22	4 (21)	15 (24)	7 (28)	0
Diplopia/Ptosis (documentation of cranial nerve palsy)	9	9 (47)#‡	1 (2)	0	0
Visual field impairment on testing*	51	4 (67)	13 (39)	12 (71)	0
GENERAL
Fatigue/weakness	10	2 (11)	7 (11)	2 (8)	1 (10)
Galactorrhea	13	0	6 (14)	1 (8)	2 (33)

Percentages are given in parentheses.

^*Percentage of visual field impairment was calculated on 57 available examinations. These are distributed as follows: 33 in group CYS; 6 in group MAL; 17 in group BEN; 1 in group INF

^**p<0.05 vs. the other groups

^#p<0.001 vs. group BEN or CYS

^‡p<0.05 vs. group INF